The properties of A-69412: A small hydrophilic 5-lipoxygenase inhibitor
- 1 January 1993
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 38 (1-2) , 178-187
- https://doi.org/10.1007/bf01976209
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitorInternational Journal of Immunopharmacology, 1992
- Glucuronidation of zileuton (A-64077) by human hepatic microsomes.1992
- Inhibition of leukotriene biosynthesis in the rat peritoneal cavityEuropean Journal of Pharmacology, 1991
- The Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced by Cold, Dry AirNew England Journal of Medicine, 1990
- Inhibition of UDP‐glucuronosyltransferase activity by possible transition‐state analogues in rat‐liver microsomesEuropean Journal of Biochemistry, 1990
- Selective 5-lipoxygenase inhibition in ulcerative colitisThe Lancet, 1990
- Cellular and Molecular Aspects of Udp-GlucuronosyltransferasesDrug Metabolism Reviews, 1989
- Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesisJournal of Medicinal Chemistry, 1988
- Selective inhibition of arachidonate 5‐lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivoBritish Journal of Pharmacology, 1988
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983